Metolazone — Discount Pricing
Metolazone is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Metolazone Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $144.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Metolazone
Metolazone is a prescription medication. Ask your doctor if Metolazone is right for you.
How to Check Metolazone Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Metolazone at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Heart & Cardiovascular
About Metolazone
Metolazone is a potent diuretic often prescribed to manage conditions like high blood pressure and fluid retention. At TheDrugClub, we believe that essential medication should be accessible and affordable. Discover how our members can enjoy significant savings on metolazone, including a $0 co-pay and the convenience of free home delivery, making health management simpler and more budget-friendly.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Metolazone is approved for (FDA label)
Metolazone tablets are indicated for the treatment of salt and water retention including: edema accompanying congestive heart failure; edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. Metolazone tablets are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. Mykrox ® tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. A dose titration is necessary if Mykrox ® tablets are to be substituted for Zaroxolyn ® tablets and other formulations of metolazone that share its slow and incomplete bioavailability, in the treatment of hypertension.
Source: Read the full FDA label on DailyMed. Label effective date: August 12, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Metolazone (FDA label)
Metolazone is usually well tolerated, and most reported adverse reactions have been mild and transient. Many metolazone related adverse reactions represent extensions of its expected pharmacologic activity and can be attributed to either its antihypertensive action or its renal/metabolic actions. The following adverse reactions have been reported. Several are single or comparably rare occurrences. Adverse reactions are listed in decreasing order of severity within body systems. Cardiovascular: Chest pain/discomfort, orthostatic hypotension, excessive volume depletion, hemoconcentration, venous thrombosis, palpitations. Central and Peripheral Nervous System: Syncope, neuropathy, vertigo, paresthesias, psychotic depression, impotence, dizziness/lightheadedness, drowsiness, fatigue, weakness, restlessness (sometimes resulting in insomnia), headache.
Source: FDA prescribing information (DailyMed). Set ID: efa8795e-2c89-4519-b49f-13146fb9ded1. SPL document ID: 58dae07d-ba01-99ad-e063-6394a90a2b62. Label effective date: August 12, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Metolazone (FDA label)
Anuria, hepatic coma or precoma, known allergy or hypersensitivity to metolazone.
Source: FDA prescribing information (DailyMed). Set ID: efa8795e-2c89-4519-b49f-13146fb9ded1. SPL document ID: 58dae07d-ba01-99ad-e063-6394a90a2b62. Label effective date: August 12, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.